Cardior Pharmaceuticals
GermanyWho owns Cardior Pharmaceuticals?
Cardior Pharmaceuticals is a German Biotech company, now owned by Novo Nordisk, which acquired it in 2024 from coparion and Sunstone Life Science Ventures.
Hand-verified · updated 2026-07-03
Open JSON · CC-BYKey facts
- ·Fully exited in 2024 to Novo Nordisk.
- ·Average hold across 2 realized cycles: 3 years.
Ownership history
2 ownership periods · co-invest detected
coparion sold Cardior Pharmaceuticals to Novo Nordisk in 2024 after 3 years.
Sunstone Life Science Ventures sold Cardior Pharmaceuticals to Novo Nordisk in 2024 after 3 years.
More from Sunstone Life Science Ventures V
Other portfolio companies in the same fund.
Italy
France
Netherlands
Belgium
DenmarkMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Cardior Pharmaceuticals?
Cardior Pharmaceuticals is now owned by Novo Nordisk, which acquired it in 2024 from coparion and Sunstone Life Science Ventures.
When did Novo Nordisk acquire Cardior Pharmaceuticals?
Novo Nordisk acquired Cardior Pharmaceuticals in 2024, buying from coparion and Sunstone Life Science Ventures.
Who did Cardior Pharmaceuticals sell to?
coparion and Sunstone Life Science Ventures sold Cardior Pharmaceuticals to Novo Nordisk in 2024 (Trade Sale).
Who has owned Cardior Pharmaceuticals over time?
Cardior Pharmaceuticals has been through 2 private-equity ownership periods: coparion · via coparion · 2021–2024 · sold to Novo Nordisk · (Trade Sale); Sunstone Life Science Ventures · via Sunstone Life Science Ventures V · 2021–2024 · sold to Novo Nordisk · (Trade Sale).